Enterprises
In The News
Disruptive Innovation — a Silver Lining to the COVID-19 Pandemic
Morning Consult - December 16th, 2020
A silver lining is defined as: a sign of hope in an unfortunate or gloomy situation; a bright prospect. As in the old saying “every dark cloud has a silver lining.”
​
With the recent announcements of multiple COVID-19 vaccine candidates showing efficacy of greater than 90 percent and with an apparently acceptable safety profile, we can begin to see an end to our current nightmare.
Treatment Before Vaccine: How These Two Medical Scientists Hope to Buy Time for COVID-19 Patients
StartUp Health - June 16th, 2020
Sen-Jam Pharmaceutical’s Jacqueline Iversen, RPh, and AdvancedDx Biological Laboratories’ CEO Dr. Anthony Japour have developed pharma and diagnostic solutions that focus on taming the immunologic response in COVID-19 patients. Their work could offer a bridge to health for those hardest hit by the virus, while the world waits for a vaccine. Here’s how.
​
​
AdvancedDx Biological Laboratories Launches in the U.S. to Bring COVID-19 Diagnostic and Antibody Tests to Local Communities
AdvancedDx Biological Laboratories - May 1st, 2020
AdvancedDx Biological Laboratories USA Inc. (ABLDx), a virologic diagnostic solutions company, announced today its official launch in the U.S. to commercialize solutions that will advance public health in the Americas. The company will be focused on fighting the COVID-19 global pandemic, bringing tests to support the front lines in local communities in the U.S. with an initial emphasis on the greater Boston area and the South Florida region, and then nationwide.
​
Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.?
Dr. Anthony Japour, Camillo Ricordi, Stat News - August 27th, 2019
​
The term “type 1 diabetes” generally conjures up images of insulin. That makes sense, because insulin is the main treatment for this common disease. But it isn’t a cure. A type of cell transplant that comes close to a cure for some people with type 1 diabetes, a technique pioneered and tested in the United States, is now available in many countries but is still deemed an experimental procedure in the U.S., making it almost impossible to get.
​
A Call to Action for the Opioid Epidemic in the United States
Dr. Anthony Japour, The Hill - April 15th, 2019
​
The recent departure of Dr. Scott Gottlieb from the helm of the Food and Drug Administration (FDA) provides a fresh opportunity to review where we go next on one of our most immediate issues: our national response to the opioid crisis.
​
iTolerance, Inc., a Company Pioneering Regenerative Medicine Without Immunosuppression, Announces Leadership Team
June 9, 2021
​
iTolerance, Inc., a biotechnology company focused on the development of innovative regenerative medicines, today announced the formation of its Executive Leadership Team with the hiring of Anthony Japour, M.D. as Chief Executive Officer and Camillo Ricordi, M.D. as Chief Scientist.
​